The main research areas of the group are:

• Modeling Emerging Viruses: building viral platforms to model and study the different stages of the viral life cycle of emerging viruses.
• Virus-Host Interactions: deciphering host factors engaged by viruses in driving the viral pathogenesis.
• Antivirals Development: identifying drug candidates for therapeutic control of viral infections.
• Oncolytic Viro-Immunotherapy: engineering and reprogramming viral vectors for highly targeted cancer treatments